InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Imricor Medical Systems Inc (ASX:IMR)

ALERT: Price-sensitive ASX Announcement for IMR
Current share price for IMR : $1.895 -0.005 (-0.26%)+
Announcement
Release
10 Aug 2026 8:50AM
Price at Release
$1.900
Full Release
download
Summary
Imricor Medical Systems Inc., a company listed on ASX, announced that Children’s Medical Center Dallas will adopt its NorthStar interventional magnetic resonance (iMR) mapping and guidance system, marking it as the second U.S. customer. This adoption underscores the growing commercial momentum of Imricor’s U.S. operations, following shortly after the partnership with Rady Children’s Hospital-San Diego. The NorthStar system, notable for enabling 100% radiation-free cardiac catheterisation procedures, is compatible with major MRI systems from Philips and Siemens, significantly expanding Imricor’s market presence. With several other U.S. hospitals nearing the completion of their purchasing processes, Imricor is poised for further expansion within the domestic market.
Key Points
  • Children’s Medical Center Dallas is the second U.S. customer for Imricor's NorthStar iMR system.
  • Imricor's U.S. commercial momentum is accelerating with rapid adoption of its technology.
  • The NorthStar system offers 100% radiation-free procedures for congenital heart disease.
  • Imricor's technology is compatible with Philips and Siemens MRI systems.
  • Several U.S. hospitals are in the final stages of purchasing Imricor's NorthStar system.
  • The adoption of NorthStar is seen as a validation of Imricor's technology in the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.